In the latest quarter, 7 analysts provided ratings for Globus Medical (NYSE:GMED), showcasing a mix of bullish and bearish perspectives.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 4 | 2 | 1 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 2 | 2 | 1 | 0 | 0 |
| 2M Ago | 0 | 0 | 0 | 0 | 0 |
| 3M Ago | 1 | 0 | 0 | 0 | 0 |
Analysts have recently evaluated Globus Medical and provided 12-month price targets. The average target is $70.0, accompanied by a high estimate of $85.00 and a low estimate of $60.00. Witnessing a positive shift, the current average has risen by 9.09% from the previous average price target of $64.17.
Interpreting Analyst Ratings: A Closer Look
An in-depth analysis of recent...
Login or create a forever free account to read this news
Sign up/Log in